NOVELION THERAPEUTICS INC. (11) | License Agreements (1)
- License Agreement, dated February 5, 2019, by and between Aegerion Pharmaceuticals, Inc. and Recordati Rare Diseases Inc (Filed With SEC on May 7, 2019)
© 2023 Justia
